These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8522386)

  • 1. Breakthrough fungemia caused by Candida stellatoidea in a patient with lymphoma associated with shock, successfully treated with amphotericin B lipid complex.
    Sufliarsky J; Sorkovska D; Kunova A; Helpianska L; Krcméry V
    Infection; 1995; 23(4):246-7. PubMed ID: 8522386
    [No Abstract]   [Full Text] [Related]  

  • 2. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.
    Minari A; Hachem R; Raad I
    Clin Infect Dis; 2001 Jan; 32(2):186-90. PubMed ID: 11170906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakthrough fungemia due to Hansenula anomala in a leukemia patient successfully treated with amphotericin B.
    Kunovà A; Spànik S; Kollàr T; Krcméry V
    J Chemother; 1996 Feb; 8(1):85-6. PubMed ID: 8835116
    [No Abstract]   [Full Text] [Related]  

  • 4. Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia.
    Myoken Y; Kyo T; Kohara T; Fujihara M; Sugata T; Mikami Y
    Clin Infect Dis; 2003 Jun; 36(11):1496-7. PubMed ID: 12766847
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of amphotericin B in lipid emulsion for treating fungal septicemia in granulocytopenic patients.
    Macedo MC; Dulley FL; Ostronoff M; Machado CM; Zambon E; Matsumoto C; Dorlhiac-Llaccer P; Chamone DF
    Clin Infect Dis; 1994 Aug; 19(2):366-7. PubMed ID: 7986930
    [No Abstract]   [Full Text] [Related]  

  • 6. Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
    Fanci R
    J Chemother; 2009 Feb; 21(1):105-7. PubMed ID: 19297283
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of caspofungin and amphotericin B for invasive candidiasis.
    Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
    N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated fungemia due to Candida krusei with cutaneous lesions and successful treatment by amphotericin B lipid complex and catheter removal: a case report.
    Hourez R; Gillard PH; Mariat P; Aoun M
    Int J Infect Dis; 2002 Dec; 6(4):326-8. PubMed ID: 12725216
    [No Abstract]   [Full Text] [Related]  

  • 9. Candida parapsilosis sepsis in patients with burns: report of six cases.
    Green D; Still JM; Law EJ
    J Burn Care Rehabil; 1994; 15(3):240-3. PubMed ID: 8056814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough fungemia due to Hansenula anomala in a leukemic patient successfully treated with amphotericin B.
    Kunová A; Spánik S; Kollár T; Trupl J; Krcméry V
    Chemotherapy; 1996; 42(2):157-8. PubMed ID: 8697892
    [No Abstract]   [Full Text] [Related]  

  • 11. [Candida rugosa fungemia: new emergent infection case].
    Villanal Cajoto I; Otero LR; Casal MA
    Rev Chilena Infectol; 2010 Feb; 27(1):87-8. PubMed ID: 20140322
    [No Abstract]   [Full Text] [Related]  

  • 12. Echinocandins--an advance in the primary treatment of invasive candidiasis.
    Walsh TJ
    N Engl J Med; 2002 Dec; 347(25):2070-2. PubMed ID: 12490691
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of candidemia on caspofungin therapy: a case report.
    Cheung C; Guo Y; Gialanella P; Feldmesser M
    Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents.
    Pan SC; Hsieh SM; Chang SC; Lee HT; Chen YC
    Med Mycol; 2005 Dec; 43(8):731-4. PubMed ID: 16422304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspofungin in combination with amphotericin B against Candida glabrata.
    Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida albicans brain abscesses in a premature infant treated with amphotericin B, flucytosine and fluconazole.
    Kamitsuka MD; Nugent NA; Conrad PD; Swanson TN
    Pediatr Infect Dis J; 1995 Apr; 14(4):329-31. PubMed ID: 7603822
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients.
    Abele-Horn M; Kopp A; Sternberg U; Ohly A; Dauber A; Russwurm W; Büchinger W; Nagengast O; Emmerling P
    Infection; 1996; 24(6):426-32. PubMed ID: 9007589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrence of two different opportunistic mycoses complicated by visceral dissemination diagnosed in "AIDS presenter" patients: candidiasis and cryptococcosis.
    Manfredi R; Calza L
    J Chemother; 2007 Jun; 19(3):350-1. PubMed ID: 17594935
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant.
    Natale F; Castronovo A; Regoli D; De Curtis M; Manzoni P
    Pediatr Infect Dis J; 2009 May; 28(5):452. PubMed ID: 19295457
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of central venous catheter fungal infection using liposomal amphotericin-B lock therapy.
    Buckler BS; Sams RN; Goei VL; Krishnan KR; Bemis MJ; Parker DP; Murray DL
    Pediatr Infect Dis J; 2008 Aug; 27(8):762-4. PubMed ID: 18664989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.